Summary
Eli Lilly and Company (LLY) filed an 8-K on October 25, 2016, to report its financial results for the third quarter and the first nine months of 2016. This filing includes a press release with unaudited financial statements, providing investors with key performance indicators and operational updates for the period ending September 30, 2016. While the 8-K itself is a procedural filing to house the earnings release, the attached press release (Exhibit 99.1) is the crucial document for investors. It details the company's revenue, earnings per share (EPS), and other financial metrics, offering insights into the company's operational performance and financial condition during the specified periods. Investors should review Exhibit 99.1 for specific financial figures and any management commentary on business trends and outlook.
Key Highlights
- 1Filing reports financial results for the third quarter and nine-month period ended September 30, 2016.
- 2The primary content is a press release (Exhibit 99.1) containing unaudited financial statements.
- 3The information is furnished, not filed, per Section 18 of the Exchange Act, meaning it doesn't carry the same liability as a fully filed document but serves as official disclosure.
- 4This 8-K serves as the formal mechanism to disseminate the Q3 2016 earnings information to the public and the SEC.
- 5Investors are directed to Exhibit 99.1 for detailed financial performance data and operational highlights.
- 6The report's event date is October 24, 2016, with the filing date on October 25, 2016, indicating the earnings announcement occurred on or around these dates.